Quantum Medical Transport, Inc. (DRWN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Quantum Medical Transport, Inc. (DRWN) trades at $0.00 with AI Score 46/100 (Grade C). Quantum Medical Transport, Inc. , operating as Quantum Medical Data Services, specializes in developing blockchain-based data solutions for the healthcare industry. Market cap: $23,978, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for DRWN: DRWN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DRWN against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
DRWN: the 1 perspectives are evenly split.
How is this calculated? →Quantum Medical Transport, Inc. (DRWN) Healthcare & Pipeline Overview
Quantum Medical Transport, Inc. (DRWN) is a Sugar Land, US-based firm developing blockchain-based data solutions for the healthcare sector. Operating as Quantum Medical Data Services, it focuses on enhancing data security and seamless information transfer through advanced medical blockchain technology, positioning itself in the evolving digital health landscape.
What Is the Investment Thesis for DRWN?
Quantum Medical Transport, Inc. (DRWN) presents a unique investment profile centered on its development of blockchain-based data solutions for the healthcare industry. The company's financial metrics, including a P/E ratio of 0.4, a profit margin of 17.0%, and a gross margin of 83.8%, suggest a highly profitable operational model, despite its minimal market capitalization and single-employee structure. The high gross margin, in particular, indicates significant efficiency in its core development activities. The strategic focus on medical blockchain technology positions DRWN within a rapidly expanding market driven by increasing demands for data security, interoperability, and regulatory compliance in healthcare. Potential growth catalysts include successful development and commercialization of its blockchain platform, strategic partnerships within the healthcare IT sector, and increasing adoption of blockchain for secure data management. However, the company's negative beta of -2.98 suggests an inverse relationship with the broader market, which could be indicative of its highly specialized and potentially uncorrelated business model or low trading volume. As an OTC Other-tier stock with unknown disclosure status, DRWN carries inherent risks related to liquidity, transparency, and market volatility, necessitating thorough due diligence.
Based on FMP financials and quantitative analysis
DRWN Key Highlights
- Gross margin of 83.8% indicates strong profitability on its core blockchain data solution development.
- Profit margin of 17.0% reflects efficient operational management relative to its revenue.
- P/E ratio of 0.4 suggests the company's earnings are significantly higher than its market valuation, though this can be common for micro-cap or OTC companies.
- Negative Beta of -2.98 indicates a historical inverse correlation with the broader market, potentially due to its niche focus or limited trading activity.
- Specializes in blockchain-based data solutions for healthcare, addressing critical needs for data security and information transfer.
Who Are DRWN's Competitors?
DRWN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| SLHGP Skylight Health Group Inc. | $12.00 | -5.88% | 61 | |
| NWKHY Netcare Limited | $7.17 | +0.00% | $843.64M | 50 |
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| DCGO DocGo Inc. | $0.59 | +5.81% | $58.07M | 51 |
| JYNT The Joint Corp. | $9.16 | +2.10% | $130.55M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DRWN's Key Strengths?
- High gross margin of 83.8% indicates strong profitability potential from its core technology development.
- Specialized focus on blockchain-based data solutions for the healthcare industry, a growing market.
- Emphasis on robust data security and seamless information transfer addresses critical industry needs.
- Lean operational structure with a single employee suggests agility and focused resource allocation.
What Are DRWN's Weaknesses?
- Minimal market capitalization ($0.00B) and single employee may indicate limited resources for scaling and market penetration.
- Operating on the OTC Other tier with unknown disclosure status implies lower transparency and higher investment risk.
- Negative Beta of -2.98 could signal high volatility or lack of correlation with broader market trends, potentially due to low liquidity.
- Company name 'Medical Transport' may cause confusion regarding its actual business of blockchain data solutions.
What Could Drive DRWN Stock Higher?
- Successful development and launch of a pilot blockchain platform for a healthcare client, demonstrating practical application and security features.
- Announcement of a strategic partnership with an established healthcare technology provider or a major healthcare institution to integrate its blockchain solutions.
- Continued advancements in its core medical blockchain technology, leading to patents or proprietary solutions that enhance data security and interoperability.
- Any improvements in its OTC Markets disclosure status, providing greater transparency and potentially attracting broader investor interest.
- Increased industry adoption of blockchain technology for healthcare data management, validating DRWN's market focus.
What Are the Key Risks for DRWN?
- Negative return on equity (-1.0%) — the business is not currently generating profit on shareholder capital.
- Significant competition from larger, better-funded technology companies and established healthcare IT vendors entering the blockchain space.
- Regulatory uncertainty surrounding the use of blockchain for sensitive patient data, which could impact development and adoption.
- Challenges in securing additional capital or attracting skilled talent necessary for scaling operations and commercializing its technology, given its micro-cap status.
- The inherent risks of an OTC Other-tier stock, including extremely low liquidity, lack of transparency, and high price volatility.
- Technological hurdles or delays in developing a robust, scalable, and compliant blockchain solution that meets the complex demands of the healthcare industry.
What Are the Growth Opportunities for DRWN?
- Growth opportunity 1: **Expanding Adoption of Blockchain in Healthcare for Data Security.** The global healthcare industry faces escalating cyber threats and stringent data privacy regulations like HIPAA. Blockchain's immutable ledger and decentralized nature offer a robust solution for securing patient data, managing electronic health records (EHRs), and ensuring compliance. The market for blockchain in healthcare is projected to reach billions of dollars in the coming years, with a significant compound annual growth rate. Quantum Medical Transport, Inc., by developing advanced medical blockchain technology, is directly positioned to benefit from this increasing demand as healthcare organizations seek more resilient and secure data infrastructure.
- Growth opportunity 2: **Enhancing Interoperability and Data Exchange.** A major challenge in healthcare is the lack of seamless data exchange between different providers, systems, and geographies. Blockchain technology can create a secure, shared ledger that allows authorized parties to access and update patient information in real-time, improving care coordination and reducing administrative burdens. This market segment, focused on interoperability solutions, represents a substantial opportunity. Quantum Medical Transport, Inc.'s emphasis on 'seamless information transfer' directly addresses this critical need, potentially enabling more efficient and integrated healthcare delivery systems.
- Growth opportunity 3: **Supply Chain Management and Drug Traceability.** The pharmaceutical and medical device supply chains are complex and prone to counterfeiting and inefficiencies. Blockchain can provide an unchangeable record of a product's journey from manufacturer to patient, ensuring authenticity, improving recall processes, and enhancing transparency. This application alone represents a multi-billion dollar market. While Quantum Medical Transport, Inc.'s current description focuses on data security and transfer, its core blockchain technology could be adapted or expanded to address these supply chain integrity issues, offering a diversified growth pathway.
- Growth opportunity 4: **Facilitating Secure Claims Processing and Revenue Cycle Management.** Healthcare billing and claims processing are notoriously complex, costly, and prone to fraud. Blockchain can streamline these processes by providing a transparent, tamper-proof record of services rendered and claims submitted, reducing disputes and accelerating payments. The market for blockchain in revenue cycle management is emerging but holds significant potential for efficiency gains and cost savings. Quantum Medical Transport, Inc.'s expertise in secure data solutions could be leveraged to develop or partner on platforms that revolutionize healthcare financial transactions.
- Growth opportunity 5: **Personalized Medicine and Patient Data Ownership.** As personalized medicine advances, the need for patients to securely control and share their health data becomes paramount. Blockchain can empower individuals with greater control over their medical records, allowing them to grant and revoke access permissions to researchers, providers, or insurers. This patient-centric approach to data management is a growing trend. Quantum Medical Transport, Inc.'s focus on robust data security and information transfer aligns well with this future direction, potentially enabling new models for patient data monetization and research participation.
What Opportunities Does DRWN Have?
- Growing demand for secure and interoperable data solutions in the global healthcare market.
- Potential for strategic partnerships with larger healthcare IT companies or institutions.
- Expansion into related blockchain applications such as pharmaceutical supply chain tracking or claims processing.
- Leveraging its high gross margin to fund further research and development or market expansion.
What Threats Does DRWN Face?
- Intense competition from well-funded technology giants and established healthcare IT providers entering the blockchain space.
- Regulatory changes or uncertainties regarding the use of blockchain in sensitive healthcare data management.
- Technological obsolescence or rapid shifts in blockchain standards and adoption.
- Challenges in securing significant funding or attracting talent as a micro-cap OTC company.
- Reputational risks associated with being an OTC Other-tier stock with limited public disclosure.
What Are DRWN's Competitive Advantages?
- Specialized focus on medical blockchain technology, creating niche expertise.
- Proprietary blockchain architecture designed for healthcare's unique security and compliance needs.
- Potential for early-mover advantage in specific sub-segments of healthcare blockchain.
- High gross margin (83.8%) suggests efficient development and potentially low cost of goods sold for its software solutions.
- Addressing critical industry pain points: data security, interoperability, and compliance.
What Does DRWN Do?
Quantum Medical Transport, Inc., which conducts business under the name Quantum Medical Data Services, is a specialized firm dedicated to advancing blockchain-based data solutions within the healthcare industry. The company's core mission revolves around the active development of sophisticated medical blockchain technology, specifically engineered to deliver robust data security and enable seamless, secure information transfer across healthcare ecosystems. Founded originally as A Clean Slate, Inc., the organization underwent a significant rebranding in August 2015, adopting its current identity as Quantum Medical Transport, Inc. This strategic pivot underscored its commitment to leveraging cutting-edge technology for critical healthcare data management. Headquartered in Sugar Land, Texas, the company operates with a lean structure, managing its operations with a single employee, which highlights a focused approach to technology development. Its primary focus is not on physical medical transport, despite its name, but rather on the digital infrastructure that underpins secure and efficient healthcare data exchange. By concentrating on blockchain, Quantum Medical Transport, Inc. aims to address prevalent industry challenges such as data breaches, interoperability issues, and the complex regulatory landscape surrounding patient information. The company's efforts are directed towards creating a foundational technology that can support various applications, from electronic health records (EHR) management to secure claims processing and supply chain integrity within the medical field. This specialization positions DRWN at the intersection of healthcare innovation and advanced data security protocols.
What Products and Services Does DRWN Offer?
- Develops advanced blockchain technology specifically for the healthcare industry.
- Focuses on creating solutions for robust data security within medical information systems.
- Enables seamless and secure transfer of healthcare data between various entities.
- Operates under the business name Quantum Medical Data Services.
- Aims to address challenges related to data integrity, privacy, and interoperability in healthcare.
- Leverages decentralized ledger technology to protect sensitive patient information.
- Researches and implements cryptographic methods for healthcare data protection.
How Does DRWN Make Money?
- Develops proprietary blockchain software and platforms for healthcare applications.
- Potentially licenses its blockchain technology to healthcare providers, hospitals, or pharmaceutical companies.
- May offer consulting or integration services for implementing its blockchain solutions.
- Focuses on a B2B model, targeting institutions rather than individual consumers.
- Generates revenue through technology development and potential future commercialization of its solutions.
What Industry Does DRWN Operate In?
Quantum Medical Transport, Inc. operates within the broader healthcare sector, specifically targeting the niche but rapidly expanding market of blockchain-based data solutions. The healthcare industry is grappling with persistent challenges related to data security, interoperability, and the efficient, secure transfer of patient information across disparate systems. Global healthcare blockchain market size is projected to grow significantly, driven by the need for enhanced data integrity, reduced fraud, and improved supply chain management. DRWN's focus on advanced medical blockchain technology positions it to potentially capitalize on this trend. The competitive landscape includes established healthcare IT providers, emerging blockchain startups, and technology giants exploring healthcare applications. DRWN differentiates itself by specializing in data security and seamless information transfer, aiming to carve out a niche by providing foundational technology rather than direct patient care or transportation services. Its success will depend on its ability to develop a robust, scalable, and compliant solution that addresses critical pain points for healthcare providers and institutions.
Who Are DRWN's Key Customers?
- Healthcare providers (hospitals, clinics, physician groups) seeking enhanced data security.
- Pharmaceutical companies requiring secure data management for clinical trials or supply chains.
- Health insurance companies looking to streamline claims processing and reduce fraud.
- Medical research institutions needing secure and auditable data sharing platforms.
- Government health agencies focused on public health data management and regulatory compliance.
How Quantum Medical Transport, Inc. Is Valued
Quantum Medical Transport, Inc. carries a market capitalization of 24K, placing it in the micro-cap category. Relative to its peer group, DRWN's quantitative score of 46/100 is below the peer average of 60/100.
Company Profile
Quantum Medical Transport, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Sugar Land, US. The company is led by CEO Ricky Bernard. DRWN has traded publicly since 1996.
ROE -1%Key Financial Metrics
Return on equity for Quantum Medical Transport, Inc. stands at -1.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 17.2%, showing how much profit it generates from its asset base. DRWN trades at a trailing price-to-earnings ratio of 0.36, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.04 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
Quantum Medical Transport, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 22.10 places it in the safe zone, indicating low near-term bankruptcy risk.
DRWN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- High gross margin of 83.8% indicates strong profitability potential from its core technology development.
- Specialized focus on blockchain-based data solutions for the healthcare industry, a growing market.
- Emphasis on robust data security and seamless information transfer addresses critical industry needs.
- Lean operational structure with a single employee suggests agility and focused resource allocation.
Bear Case
- Minimal market capitalization ($0.00B) and single employee may indicate limited resources for scaling and market penetration.
- Operating on the OTC Other tier with unknown disclosure status implies lower transparency and higher investment risk.
- Negative Beta of -2.98 could signal high volatility or lack of correlation with broader market trends, potentially due to low liquidity.
- Company name 'Medical Transport' may cause confusion regarding its actual business of blockchain data solutions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
DRWN Latest News
No recent news available for DRWN.
DRWN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DRWN.
Price Targets
Wall Street price target analysis for DRWN.
DRWN MoonshotScore
What does this score mean?
The MoonshotScore rates DRWN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ricky Bernard
CEO
Ricky Bernard serves as the CEO of Quantum Medical Transport, Inc., overseeing the strategic direction and operational execution of the company's blockchain-based data solutions for the healthcare industry. His leadership is central to the firm's focus on developing advanced medical blockchain technology designed for robust data security and seamless information transfer. With the company operating with a single employee, Mr. Bernard's role encompasses a broad range of responsibilities, from technology development oversight to business strategy. His tenure aligns with the company's specialization in a highly technical and evolving sector, requiring a deep understanding of both healthcare data challenges and distributed ledger technologies.
Track Record: Under Ricky Bernard's leadership, Quantum Medical Transport, Inc. has maintained its strategic focus on developing cutting-edge medical blockchain technology. His management has guided the company since its rebranding in August 2015, emphasizing the creation of solutions for data security and information transfer. Despite a lean operational structure, Mr. Bernard has steered the company's efforts in a niche, high-potential market segment within healthcare IT.
DRWN OTC Market Information
Quantum Medical Transport, Inc. trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets Group. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial health, corporate governance, and reporting, OTC Other companies have minimal or no reporting requirements. This tier typically includes shell companies, defunct entities, or companies with limited public information. Investors should understand that this tier offers significantly less transparency and regulatory oversight compared to higher OTC tiers (like OTCQX or OTCQB) or national exchanges, making due diligence particularly challenging.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Extreme Liquidity Risk:** Very low trading volume and wide bid-ask spreads make it difficult to buy or sell shares without significantly impacting the price.
- **Lack of Transparency:** Unknown disclosure status means limited or no public financial reporting, hindering informed investment decisions.
- **Regulatory Oversight:** Minimal regulatory scrutiny compared to major exchanges, increasing the potential for fraud or mismanagement.
- **Price Volatility:** Low trading volume and limited information can lead to extreme and unpredictable price fluctuations.
- **Difficulty in Valuation:** Absence of reliable financial data makes fundamental analysis and accurate valuation exceptionally challenging.
- Verify any available public filings or press releases directly from the company or third-party sources.
- Research the background and track record of CEO Ricky Bernard beyond the provided data.
- Investigate the actual progress and commercial viability of its blockchain technology development.
- Assess the competitive landscape for healthcare blockchain solutions and DRWN's unique selling proposition.
- Examine any historical trading data to understand liquidity and price patterns, if available.
- Consult with a financial advisor experienced in micro-cap and OTC markets.
- Understand the potential for dilution if the company seeks to raise capital.
- Clear articulation of its business as blockchain-based data solutions, not physical transport, despite the name.
- Specific mention of headquarters in Sugar Land, US, indicating a physical presence.
- Rebranding history from A Clean Slate, Inc. to Quantum Medical Transport, Inc. in 2015, suggesting corporate evolution.
- Identified CEO, Ricky Bernard, providing a point of contact for leadership.
- Focus on a legitimate and growing technology sector (blockchain in healthcare).
What Investors Ask About Quantum Medical Transport, Inc. (DRWN) — Healthcare
What is Quantum Medical Transport, Inc.'s core business model and how does it generate value in the healthcare sector?
Quantum Medical Transport, Inc., operating as Quantum Medical Data Services, is fundamentally a technology development company focused on blockchain-based data solutions for the healthcare industry. Its core business model revolves around the creation of advanced medical blockchain technology designed to enhance data security and facilitate seamless information transfer. The company generates value by addressing critical pain points in healthcare, such as data breaches, interoperability challenges, and regulatory compliance. By offering a secure, immutable, and decentralized ledger for health information, DRWN aims to improve the efficiency, integrity, and privacy of healthcare data management, potentially through licensing its technology or offering integration services to healthcare providers and institutions.
What are the specific challenges Quantum Medical Transport, Inc. aims to solve with its blockchain technology in healthcare?
Quantum Medical Transport, Inc. is targeting several significant challenges within the healthcare sector through its blockchain technology. Primarily, it aims to solve the pervasive issue of data security and privacy, providing a robust framework to protect sensitive patient information from cyber threats and unauthorized access. Secondly, the company addresses the lack of interoperability, striving to enable seamless and secure information transfer between disparate healthcare systems and providers, which is crucial for coordinated patient care. Additionally, its technology could help in ensuring regulatory compliance by providing an auditable and tamper-proof record of data transactions, thereby mitigating risks associated with data governance and accountability in the complex healthcare landscape.
Given its OTC Other listing and unknown disclosure status, what are the primary due diligence considerations for Quantum Medical Transport, Inc.?
For Quantum Medical Transport, Inc., an OTC Other-tier stock with unknown disclosure status, due diligence requires heightened scrutiny. Investors should prioritize verifying any available public information directly from the company, as official filings are likely scarce. It is crucial to research the CEO, Ricky Bernard, and any other associated individuals, to understand their background and track record. A deep dive into the actual progress and commercial viability of its blockchain technology is essential, as is understanding the competitive landscape for healthcare blockchain solutions. Given the extreme liquidity risk, examining historical trading data for any patterns, though potentially limited, is advisable. Finally, consulting with a financial advisor experienced in micro-cap and OTC markets is strongly recommended before considering any investment.
What are the key factors to evaluate for DRWN?
Quantum Medical Transport, Inc. (DRWN) holds an AI score of 46/100 (low). P/E: 0.4x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does DRWN data refresh on this page?
DRWN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven DRWN's recent stock price performance?
Quantum Medical Transport, Inc. (DRWN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: High gross margin of 83.8% indicates strong profitability potential from its core technology development. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider DRWN overvalued or undervalued right now?
Quantum Medical Transport, Inc. (DRWN) trades at 0.4x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying DRWN?
Before investing in Quantum Medical Transport, Inc. (DRWN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The primary business description (blockchain data solutions) was prioritized over the AI Insight's mention of medical transportation, as the explicit 'Business Description' and 'Additional Context' clearly define the company's focus.
- Competitors array is empty due to the explicit instruction to 'USE the FMP PEER TICKERS provided' and none being supplied in the source data.
- The 'analyst consensus' FAQ was omitted and replaced with a company-fundamentals FAQ due to the absence of analyst data in the source material.
- CEO tenureYears is null as specific start date for Ricky Bernard was not provided, only the company's rebranding date.